These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23531217)

  • 1. Study on medicinal chemistry of K203 in wistar rats and beagle dogs.
    Kalász H; Szegi P; Jánoki G; Balogh L; Pöstényi Z; Musilek K; Petroianu GA; Siddiq A; Tekes K
    Curr Med Chem; 2013; 20(16):2137-44. PubMed ID: 23531217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs.
    Karasova JZ; Kvetina J; Tacheci I; Radochova V; Musilek K; Kuca K; Bures J
    Toxicol Lett; 2017 May; 273():20-25. PubMed ID: 28343895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator.
    Tekes K; Hasan MY; Sheen R; Kuca K; Petroianu G; Ludányi K; Kalász H
    J Chromatogr A; 2006 Jul; 1122(1-2):84-7. PubMed ID: 16690067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of K-27, an oxime-type cholinesterase reactivator by high-performance liquid chromatography with electrochemical detection from different biological samples.
    Gyenge M; Kalász H; Petroianu GA; Laufer R; Kuca K; Tekes K
    J Chromatogr A; 2007 Aug; 1161(1-2):146-51. PubMed ID: 17603065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPLC determination of brain biogenic amines following treatment with bispyridinium aldoxime K203.
    Hashemi F; Laufer R; Szegi P; Csomor V; Kalász H; Tekes K
    Acta Physiol Hung; 2014 Mar; 101(1):40-6. PubMed ID: 24631794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPLC analysis of K-48 concentration in plasma.
    Kalász H; Hasan MY; Sheen R; Kuca K; Petroianu G; Ludányi K; Gergely A; Tekes K
    Anal Bioanal Chem; 2006 Jul; 385(6):1062-7. PubMed ID: 16763789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats.
    Kassa J; Karasova JZ; Tesarova S; Musilek K; Kuca K; Jung YS
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):861-7. PubMed ID: 22545968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Two Chlorine-Substituted Bis-Pyridinium Mono-Aldoximes with Regenerating Effect on Butyrylcholinesterase.
    Kalász H; Szimrók Z; Karvaly G; Adeghate J; Tekes K
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32164301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitor.
    Antonijevic E; Musilek K; Kuca K; Djukic-Cosic D; Vucinic S; Antonijevic B
    Neurotoxicology; 2016 Jul; 55():33-39. PubMed ID: 27177985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of two acetylcholinesterase reactivators, trimedoxime and newly synthesized oxime K027, in rat plasma.
    Karasova JZ; Chladek J; Hroch M; Josef F; Hnidkova D; Kuca K
    J Appl Toxicol; 2013 Jan; 33(1):18-23. PubMed ID: 21717485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partition of bispyridinium oximes (trimedoxime and K074) administered in therapeutic doses into different parts of the rat brain.
    Karasova JZ; Zemek F; Bajgar J; Vasatova M; Prochazka P; Novotny L; Kuca K
    J Pharm Biomed Anal; 2011 Apr; 54(5):1082-7. PubMed ID: 21146949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response modeling of reactivating potency of oximes K027 and K203 against a direct acetylcholinesterase inhibitor in rat erythrocytes.
    Antonijevic E; Musilek K; Kuca K; Djukic-Cosic D; Curcic M; Miladinovic DC; Bulat Z; Antonijevic B
    Food Chem Toxicol; 2018 Nov; 121():224-230. PubMed ID: 30176309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Musilek K; Horova A
    Toxicol Mech Methods; 2014 Mar; 24(3):173-8. PubMed ID: 24295433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats.
    Kassa J; Karasova JZ; Tesarova S
    Drug Chem Toxicol; 2011 Jul; 34(3):233-9. PubMed ID: 21649476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridinium aldoxime analysis by HPLC: the method for studies on pharmacokinetics and stability.
    Szegi P; Kalász H; Laufer R; Kuca K; Tekes K
    Anal Bioanal Chem; 2010 May; 397(2):579-86. PubMed ID: 20349225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
    Kassa J; Kunesova G
    Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice.
    Kassa J; Karasova JZ; Sepsova V; Caisberger F
    Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):30-4. PubMed ID: 21235715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.